β-Arrestin-Biased Signaling by the β-Adrenergic Receptors

Current Topics in Membranes

Volumn 67, Issue , 2011, Pages 51-78

  Shenoy, Sudha K ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bias; Ligand; Protease; Spatial; Spinophilin; Temporal

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ARRESTIN; RETINA S ANTIGEN;

ANIMAL; BIOLOGICAL MODEL; BOOK; DRUG ANTAGONISM; HUMAN; METABOLISM; PROTEIN PROCESSING; SIGNAL TRANSDUCTION;

ANIMALS; ARRESTINS; HUMANS; MODELS, BIOLOGICAL; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION;

EID: 79959731232     PISSN: 10635823     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-384921-2.00003-3     Document Type: Book

References (103)

1. Ahn S., Shenoy S.K., Wei H., Lefkowitz R.J. Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor. J Biol Chem 2004, 279(34):35518-35525.
2. Azzi M., Charest P.G., Angers S., Rousseau G., Kohout T., Bouvier M., et al. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc Natl Acad Sci USA 2003, 100(20):11406-11411.
3. Baker J.G. The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors. Br J Pharmacol 2010, 160(5):1048-1061.
4. Barber D.L., Ganz M.B., Bongiorno P.B., Strader C.D. Mutant constructs of the beta-adrenergic receptor that are uncoupled from adenylyl cyclase retain functional activation of Na-H exchange. Mol Pharmacol 1992, 41(6):1056-1060.
5. Barthet G., Carrat G., Cassier E., Barker B., Gaven F., Pillot M., et al. Beta-arrestin1 phosphorylation by GRK5 regulates G protein-independent 5-HT4 receptor signalling. Embo J 2009, 28(18):2706-2718.
6. Berthouze M., Venkataramanan V., Li Y., Shenoy S.K. The deubiquitinases USP33 and USP20 coordinate beta2 adrenergic receptor recycling and resensitization. Embo J 2009, 28(12):1684-1696.
7. Breit A., Lagace M., Bouvier M. Hetero-oligomerization between beta2- and beta3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties. J Biol Chem 2004, 279(27):28756-28765.
8. Cao T.T., Deacon H.W., Reczek D., Bretscher A., von Zastrow M. A kinase-regulated PDZ-domain interaction controls endocytic sorting of the beta2-adrenergic receptor. Nature 1999, 401(6750):286-290.
9. Charest P.G., Terrillon S., Bouvier M. Monitoring agonist-promoted conformational changes of beta-arrestin in living cells by intramolecular BRET. EMBO Rep 2005, 6(4):334-340.
10. Cheung A.H., Huang R.R., Strader C.D. Involvement of specific hydrophobic, but not hydrophilic, amino acids in the third intracellular loop of the beta-adrenergic receptor in the activation of Gs. Mol Pharmacol 1992, 41(6):1061-1065.
11. Chuang D.M., Costa E. Evidence for internalization of the recognition site of beta-adrenergic receptors during receptor subsensitivity induced by (-)-isoproterenol. Proc Natl Acad Sci USA 1979, 76(6):3024-3028.
12. Daaka Y., Luttrell L.M., Lefkowitz R.J. Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature 1997, 390(6655):88-91.
13. DeFea K.A., Zalevsky J., Thoma M.S., Dery O., Mullins R.D., Bunnett N.W. beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 2000, 148(6):1267-1281.
14. DeWire S.M., Ahn S., Lefkowitz R.J., Shenoy S.K. Beta-arrestins and cell signaling. Annu Rev Physiol 2007, 69:483-510.
15. Drake M.T., Violin J.D., Whalen E.J., Wisler J.W., Shenoy S.K., Lefkowitz R.J. beta-arrestin-biased agonism at the beta2-adrenergic receptor. J Biol Chem 2008, 283(9):5669-5676.
16. Ferguson S.S., Downey W.E., Colapietro A.M., Barak L.S., Menard L., Caron M.G. Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science 1996, 271(5247):363-366.
17. Fredericks Z.L., Pitcher J.A., Lefkowitz R.J. Identification of the G protein-coupled receptor kinase phosphorylation sites in the human beta2-adrenergic receptor. J Biol Chem 1996, 271(23):13796-13803.
18. Freedman N.J., Liggett S.B., Drachman D.E., Pei G., Caron M.G., Lefkowitz R.J. Phosphorylation and desensitization of the human beta 1-adrenergic receptor. Involvement of G protein-coupled receptor kinases and cAMP-dependent protein kinase. J Biol Chem 1995, 270(30):17953-17961.
19. Frielle T., Collins S., Daniel K.W., Caron M.G., Lefkowitz R.J., Kobilka B.K. Cloning of the cDNA for the human beta 1-adrenergic receptor. Proc Natl Acad Sci USA 1987, 84(22):7920-7924.
20. Galandrin S., Bouvier M. Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy. Mol Pharmacol 2006, 70(5):1575-1584.
21. Galandrin S., Oligny-Longpre G., Bonin H., Ogawa K., Gales C., Bouvier M. Conformational rearrangements and signaling cascades involved in ligand-biased mitogen-activated protein kinase signaling through the beta1-adrenergic receptor. Mol Pharmacol 2008, 74(1):162-172.
22. Galandrin S., Oligny-Longpre G., Bouvier M. The evasive nature of drug efficacy: Implications for drug discovery. Trends Pharmacol Sci 2007, 28(8):423-430.
23. Gesty-Palmer D., Flannery P., Yuan L., Corsino L., Spurney R., Lefkowitz R.J., et al. A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation. Sci Transl Med 2010, 1(1):1ra1.
24. Gong K., Li Z., Xu M., Du J., Lv Z., Zhang Y. A novel protein kinase A-independent, beta-arrestin-1-dependent signaling pathway for p38 mitogen-activated protein kinase activation by beta2-adrenergic receptors. J Biol Chem 2008, 283(43):29028-29036.
25. Gurevich V.V., Gurevich E.V. The molecular acrobatics of arrestin activation. Trends Pharmacol Sci 2004, 25(2):105-111.
26. Hall R.A., Ostedgaard L.S., Premont R.T., Blitzer J.T., Rahman N., Welsh M.J., et al. A C-terminal motif found in the beta2-adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger regulatory factor family of PDZ proteins. Proc Natl Acad Sci USA 1998, 95(15):8496-8501.
27. Hall R.A., Premont R.T., Chow C.W., Blitzer J.T., Pitcher J.A., Claing A., et al. The beta2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange. Nature 1998, 392(6676):626-630.
28. Hall R.A., Spurney R.F., Premont R.T., Rahman N., Blitzer J.T., Pitcher J.A., et al. G protein-coupled receptor kinase 6A phosphorylates the Na(+)/H(+) exchanger regulatory factor via a PDZ domain-mediated interaction. J Biol Chem 1999, 274(34):24328-24334.
29. Han M., Gurevich V.V., Vishnivetskiy S.A., Sigler P.B., Schubert C. Crystal structure of beta-arrestin at 1.9 A: Possible mechanism of receptor binding and membrane Translocation. Structure 2001, 9(9):869-880.
30. Hershko A., Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998, 67:425-479.
31. Hirsch J.A., Schubert C., Gurevich V.V., Sigler P.B. The 2.8 A crystal structure of visual arrestin: A model for arrestin's regulation. Cell 1999, 97(2):257-269.
32. Inglese J., Koch W.J., Caron M.G., Lefkowitz R.J. Isoprenylation in regulation of signal transduction by G-protein-coupled receptor kinases. Nature 1992, 359(6391):147-150.
33. Kenakin T., Miller L.J. Seven transmembrane receptors as shape shifting proteins: The impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol Rev 2010, 62(2):265-304.
34. Kim I.M., Tilley D.G., Chen J., Salazar N.C., Whalen E.J., Violin J.D., et al. Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation. Proc Natl Acad Sci USA 2008, 105(38):14555-14560.
35. Kim Y.M., Barak L.S., Caron M.G., Benovic J.L. Regulation of arrestin-3 phosphorylation by casein kinase II. J Biol Chem 2002, 277(19):16837-16846.
36. Klenk C., Vetter T., Zurn A., Vilardaga J.P., Friedman P.A., Wang B., et al. Formation of a ternary complex among NHERF1, beta-arrestin, and parathyroid hormone receptor. J Biol Chem 2010, 285(39):30355-30362.
37. Krupnick J.G., Goodman O.B., Keen J.H., Benovic J.L. Arrestin/clathrin interaction. Localization of the clathrin binding domain of nonvisual arrestins to the carboxy terminus. J Biol Chem 1997, 272(23):15011-15016.
38. Kuo F.T., Lu T.L., Fu H.W. Opposing effects of beta-arrestin1 and beta-arrestin2 on activation and degradation of Src induced by protease-activated receptor 1. Cell Signal 2006, 18(11):1914-1923.
39. Lagerstrom M.C., Schioth H.B. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov 2008, 7(4):339-357.
40. Lefkowitz R.J., Shenoy S.K. Transduction of receptor signals by beta-arrestins. Science 2005, 308(5721):512-517.
41. Liggett S.B., Freedman N.J., Schwinn D.A., Lefkowitz R.J. Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor. Proc Natl Acad Sci USA 1993, 90(8):3665-3669.
42. Lin F.T., Chen W., Shenoy S., Cong M., Exum S.T., Lefkowitz R.J. Phosphorylation of beta-arrestin2 regulates its function in internalization of beta(2)-adrenergic receptors. Biochemistry 2002, 41(34):10692-10699.
43. Lin F.T., Krueger K.M., Kendall H.E., Daaka Y., Fredericks Z.L., Pitcher J.A., et al. Clathrin-mediated endocytosis of the beta-adrenergic receptor is regulated by phosphorylation/dephosphorylation of beta-arrestin1. J Biol Chem 1997, 272(49):31051-31057.
44. Lin F.T., Miller W.E., Luttrell L.M., Lefkowitz R.J. Feedback regulation of beta-arrestin1 function by extracellular signal-regulated kinases. J Biol Chem 1999, 274(23):15971-15974.
45. Lohse M.J., Engelhardt S., Eschenhagen T. What is the role of beta-adrenergic signaling in heart failure?. Circ Res 2003, 93(10):896-906.
46. Luttrell L.M., Ferguson S.S., Daaka Y., Miller W.E., Maudsley S., Della Rocca G.J., et al. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 1999, 283(5402):655-661.
47. Luttrell L.M., Roudabush F.L., Choy E.W., Miller W.E., Field M.E., Pierce K.L., et al. Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc Natl Acad Sci USA 2001, 98(5):2449-2454.
48. Mangmool S., Shukla A.K., Rockman H.A. beta-Arrestin-dependent activation of Ca(2+)/calmodulin kinase II after beta(1)-adrenergic receptor stimulation. J Cell Biol 2010, 189(3):573-587.
49. Marion S., Fralish G.B., Laporte S., Caron M.G., Barak L.S. N-terminal tyrosine modulation of the endocytic adaptor function of the beta-arrestins. J Biol Chem 2007, 282(26):18937-18944.
50. Martin N.P., Whalen E.J., Zamah M.A., Pierce K.L., Lefkowitz R.J. PKA-mediated phosphorylation of the beta1-adrenergic receptor promotes Gs/Gi switching. Cell Signal 2004, 16(12):1397-1403.
51. Maudsley S., Pierce K.L., Zamah A.M., Miller W.E., Ahn S., Daaka Y., et al. The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor. J Biol Chem 2000, 275(13):9572-9580.
52. Milano S.K., Kim Y.M., Stefano F.P., Benovic J.L., Brenner C. Nonvisual arrestin oligomerization and cellular localization are regulated by inositol hexakisphosphate binding. J Biol Chem 2006, 281(14):9812-9823.
53. Miller W.E., Lefkowitz R.J. Expanding roles for beta-arrestins as scaffolds and adapters in GPCR signaling and trafficking. Curr Opin Cell Biol 2001, 13(2):139-145.
54. Nantel F., Bonin H., Emorine L.J., Zilberfarb V., Strosberg A.D., Bouvier M., et al. The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization. Mol Pharmacol 1993, 43(4):548-555.
55. Neves S.R., Ram P.T., Iyengar R. G protein pathways. Science 2002, 296(5573):1636-1639.
56. Nikolaev V.O., Moshkov A., Lyon A.R., Miragoli M., Novak P., Paur H., et al. Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science 2010, 327(5973):1653-1657.
57. Nobles K.N., Guan Z., Xiao K., Oas T.G., Lefkowitz R.J. The active conformation of beta-arrestin1: direct evidence for the phosphate sensor in the N-domain and conformational differences in the active states of beta-arrestins1 and -2. J Biol Chem 2007, 282(29):21370-21381.
58. Noma T., Lemaire A., Naga Prasad S.V., Barki-Harrington L., Tilley D.G., Chen J., et al. Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection. J Clin Invest 2007, 117(9):2445-2458.
59. O'Dowd B.F., Hnatowich M., Regan J.W., Leader W.M., Caron M.G., Lefkowitz R.J. Site-directed mutagenesis of the cytoplasmic domains of the human beta 2-adrenergic receptor. Localization of regions involved in G protein-receptor coupling. J Biol Chem 1988, 263(31):15985-15992.
60. Oakley R.H., Laporte S.A., Holt J.A., Barak L.S., Caron M.G. Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis. J Biol Chem 2001, 276(22):19452-19460.
61. Oakley R.H., Laporte S.A., Holt J.A., Caron M.G., Barak L.S. Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors. J Biol Chem 2000, 275(22):17201-17210.
62. Ozawa K., Whalen E.J., Nelson C.D., Mu Y., Hess D.T., Lefkowitz R.J., et al. S-nitrosylation of beta-arrestin regulates beta-adrenergic receptor trafficking. Mol Cell 2008, 31(3):395-405.
63. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., et al. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000, 289(5480):739-745.
64. Palczewski K., Pulvermuller A., Buczylko J., Hofmann K.P. Phosphorylated rhodopsin and heparin induce similar conformational changes in arrestin. J Biol Chem 1991, 266(28):18649-18654.
65. Patel C.B., Noor N., Rockman H.A. Functional selectivity in adrenergic and angiotensin signaling systems. Mol Pharmacol 2010, 78(6):983-992.
66. Pierce K.L., Premont R.T., Lefkowitz R.J. Seven-transmembrane receptors. Nat Rev Mol Cell Biol 2002, 3(9):639-650.
67. Pitcher J.A., Freedman N.J., Lefkowitz R.J. G protein-coupled receptor kinases. Annu Rev Biochem 1998, 67:653-692.
68. Pitcher J.A., Inglese J., Higgins J.B., Arriza J.L., Casey P.J., Kim C., et al. Role of beta gamma subunits of G proteins in targeting the beta-adrenergic receptor kinase to membrane-bound receptors. Science 1992, 257(5074):1264-1267.
69. Premont R.T., Gainetdinov R.R. Physiological roles of G protein-coupled receptor kinases and arrestins. Annu Rev Physiol 2007, 69:511-534.
70. Rasmussen S.G., Choi H.J., Rosenbaum D.M., Kobilka T.S., Thian F.S., Edwards P.C., et al. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 2007, 450(7168):383-387.
71. Reiner S., Ambrosio M., Hoffmann C., Lohse M.J. Differential signaling of the endogenous agonists at the {beta}2-adrenergic receptor. J Biol Chem 2010, 285(46):36188-36198.
72. Reiter E., Lefkowitz R.J. GRKs and beta-arrestins: Roles in receptor silencing, trafficking and signaling. Trends Endocrinol Metab 2006, 17(4):159-165.
73. Rockman H.A., Koch W.J., Lefkowitz R.J. Seven-transmembrane-spanning receptors and heart function. Nature 2002, 415(6868):206-212.
74. Rojanathammanee L., Harmon E.B., Grisanti L.A., Govitrapong P., Ebadi M., Grove B.D., et al. The 27-kDa heat shock protein confers cytoprotective effects through a beta 2-adrenergic receptor agonist-initiated complex with beta-arrestin. Mol Pharmacol 2009, 75(4):855-865.
75. Salahpour A., Masri B. Experimental challenge to a 'rigorous' BRET analysis of GPCR oligomerization. Nat Methods 2007, 4(8):599-600. author reply 601.
76. Shenoy S.K., Barak L.S., Xiao K., Ahn S., Berthouze M., Shukla A.K., et al. Ubiquitination of beta-arrestin links seven-transmembrane receptor endocytosis and ERK activation. J Biol Chem 2007, 282(40):29549-29562.
77. Shenoy S.K., Drake M.T., Nelson C.D., Houtz D.A., Xiao K., Madabushi S., et al. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. J Biol Chem 2006, 281(2):1261-1273.
78. Shenoy S.K., Lefkowitz R.J. Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination. J Biol Chem 2003, 278(16):14498-14506.
79. Shenoy S.K., Lefkowitz R.J. Receptor-specific ubiquitination of beta-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes. J Biol Chem 2005, 280(15):15315-15324.
80. Shenoy S.K., McDonald P.H., Kohout T.A., Lefkowitz R.J. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science 2001, 294(5545):1307-1313.
81. Shenoy S.K., Modi A.S., Shukla A.K., Xiao K., Berthouze M., Ahn S., et al. Beta-arrestin-dependent signaling and trafficking of 7-transmembrane receptors is reciprocally regulated by the deubiquitinase USP33 and the E3 ligase Mdm2. Proc Natl Acad Sci USA 2009, 106(16):6650-6655.
82. Shiina T., Kawasaki A., Nagao T., Kurose H. Interaction with beta-arrestin determines the difference in internalization behavior between beta1- and beta2-adrenergic receptors. J Biol Chem 2000, 275(37):29082-29090.
83. Shukla A.K., Violin J.D., Whalen E.J., Gesty-Palmer D., Shenoy S.K., Lefkowitz R.J. Distinct conformational changes in beta-arrestin report biased agonism at seven-transmembrane receptors. Proc Natl Acad Sci USA 2008, 105(29):9988-9993.
84. Smith F.D., Oxford G.S., Milgram S.L. Association of the D2 dopamine receptor third cytoplasmic loop with spinophilin, a protein phosphatase-1-interacting protein. J Biol Chem 1999, 274(28):19894-19900.
85. Stadel J.M., Strulovici B., Nambi P., Lavin T.N., Briggs M.M., Caron M.G., et al. Desensitization of the beta-adrenergic receptor of frog erythrocytes. Recovery and characterization of the down-regulated receptors in sequestered vesicles. J Biol Chem 1983, 258(5):3032-3038.
86. Storez H., Scott M.G., Issafras H., Burtey A., Benmerah A., Muntaner O., et al. Homo- and hetero-oligomerization of beta-arrestins in living cells. J Biol Chem 2005, 280(48):40210-40215.
87. Tilley D.G., Kim I.M., Patel P.A., Violin J.D., Rockman H.A. beta-Arrestin mediates beta1-adrenergic receptor-epidermal growth factor receptor interaction and downstream signaling. J Biol Chem 2009, 284(30):20375-20386.
88. Vaidehi N., Kenakin T. The role of conformational ensembles of seven transmembrane receptors in functional selectivity. Curr Opin Pharmacol 2010, 10(6):775-781.
89. Violin J.D., Lefkowitz R.J. Beta-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol Sci 2007, 28(8):416-422.
90. Vishnivetskiy S.A., Schubert C., Climaco G.C., Gurevich Y.V., Velez M.G., Gurevich V.V. An additional phosphate-binding element in arrestin molecule. Implications for the mechanism of arrestin activation. J Biol Chem 2000, 275(52):41049-41057.
91. Wang Q., Limbird L.E. Regulated interactions of the alpha 2A adrenergic receptor with spinophilin, 14-3-3zeta, and arrestin 3. J Biol Chem 2002, 277(52):50589-50596.
92. Wang Q., Limbird L.E. Regulation of alpha2AR trafficking and signaling by interacting proteins. Biochem Pharmacol 2007, 73(8):1135-1145.
93. Wang Q., Lu R., Zhao J., Limbird L.E. Arrestin serves as a molecular switch, linking endogenous alpha2-adrenergic receptor to SRC-dependent, but not SRC-independent, ERK activation. J Biol Chem 2006, 281(36):25948-25955.
94. Wang Q., Zhao J., Brady A.E., Feng J., Allen P.B., Lefkowitz R.J., et al. Spinophilin blocks arrestin actions in vitro and in vivo at G protein-coupled receptors. Science 2004, 304(5679):1940-1944.
95. Wang Y., De Arcangelis V., Gao X., Ramani B., Jung Y.S., Xiang Y. Norepinephrine- and epinephrine-induced distinct beta2-adrenoceptor signaling is dictated by GRK2 phosphorylation in cardiomyocytes. J Biol Chem 2008, 283(4):1799-1807.
96. Warne T., Serrano-Vega M.J., Baker J.G., Moukhametzianov R., Edwards P.C., Henderson R., et al. Structure of a beta1-adrenergic G-protein-coupled receptor. Nature 2008, 454(7203):486-491.
97. Wisler J.W., DeWire S.M., Whalen E.J., Violin J.D., Drake M.T., Ahn S., et al. A unique mechanism of beta-blocker action: Carvedilol stimulates beta-arrestin signaling. Proc Natl Acad Sci USA 2007, 104(42):16657-16662.
98. Woo A.Y., Wang T.B., Zeng X., Zhu W., Abernethy D.R., Wainer I.W., et al. Stereochemistry of an agonist determines coupling preference of beta2-adrenoceptor to different G proteins in cardiomyocytes. Mol Pharmacol 2009, 75(1):158-165.
99. Xiang Y., Kobilka B. The PDZ-binding motif of the beta2-adrenoceptor is essential for physiologic signaling and trafficking in cardiac myocytes. Proc Natl Acad Sci USA 2003, 100(19):10776-10781.
100. Xiao K., Shenoy S.K., Nobles K., Lefkowitz R.J. Activation-dependent conformational changes in {beta}-arrestin 2. J Biol Chem 2004, 279(53):55744-55753.
101. Xiao K., Sun J., Kim J., Rajagopal S., Zhai B., Villen J., et al. Global phosphorylation analysis of beta-arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR). Proc Natl Acad Sci USA 2010, 107(34):15299-15304.
102. Zamah A.M., Delahunty M., Luttrell L.M., Lefkowitz R.J. Protein kinase A-mediated phosphorylation of the beta 2-adrenergic receptor regulates its coupling to Gs and Gi. Demonstration in a reconstituted system. J Biol Chem 2002, 277(34):31249-31256.
103. Zeitoun O., Santos N.M., Gardner L.A., White S.W., Bahouth S.W. Mutagenesis within helix 6 of the human beta1-adrenergic receptor identifies Lysine324 as a residue involved in imparting the high-affinity binding state of agonists. Mol Pharmacol 2006, 70(3):838-850.